Binding characteristics of fluoroquinolones to synthetic levodopa melanin

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 8, 2003, Pages 1127-1133

  Ono, Chiho ^a   Tanaka, Makoto ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUFFER; CARBOXYL GROUP; CHLOROQUINE; CIPROFLOXACIN; ENOXACIN; HYDROCHLORIC ACID; LEVODOPA; LEVOFLOXACIN; LOMEFLOXACIN; MELANIN; NITROGEN; NORFLOXACIN; OFLOXACIN; PHOSPHATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; SPARFLOXACIN; TIMOLOL;

ARTICLE; ATOM; BINDING AFFINITY; CONTROLLED STUDY; DRUG ADSORPTION; DRUG PROTEIN BINDING; DRUG STRUCTURE; ELECTRICITY; ENANTIOMER; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; ISOTHERM; NONHUMAN; RACEMIC MIXTURE; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

BINDING SITES; CHLOROQUINE; CIPROFLOXACIN; DRUG INTERACTIONS; ENOXACIN; FLUOROQUINOLONES; LEVODOPA; MELANINS; MONOPHENOL MONOOXYGENASE; NORFLOXACIN; OFLOXACIN; QUINOLONES; TIMOLOL;

EID: 0043026996     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235703322277168     Document Type: Article

References (22)

1. Atlasik, B., Stepien, K., Wilczok, T. (1980) Interaction of drugs with ocular melanin in vitro. Exp. Eye Res. 30: 325-331
2. Böke, W., Bäumer, A., Müller-Limmroth, W., Mludeck, M. (1967) Zur frage der chloroquinschädigung des auges. Klin. Monatsbl. Augenheilkd. 151: 617-633
3. Davidorf, F. H. (1973) Thioridazine pigmentary retinopathy. Arch. Ophthalmol. 90: 251-255
4. Fukuda, M., Sasaki, K. (1989) Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes. Lens Eye Toxic. Res. 6: 339-351
5. Fukuda, M., Sasaki, K. (1990) Changes in the antibacterial activity of melanin-bound drugs. Ophthalmic Res. 22: 123-127
6. Fukuda, M., Morita, Y., Sasaki, K., Yamamoto, Y. (2000) Studies on the binding mechanism of fluoroquinolones to melanin. J. Infect. Chemother. 6: 72-76
7. Goldman, L., Preston, R. H. (1957) Reactions to chloroquine observed during the treatment of various dermatologic disorders. Am. J. Trop. Med. Hyg. 6: 654-657
8. Hobbs, H. E., Sorsby, A., Freedman, A. (1959) Retinopathy following chloroquine therapy. Lancet 2: 478-480
9. Ings, R. M. J. (1984) The melanin binding of drugs and its implications. Drug Metab. Rev. 15: 1183-1212
10. Koneru, P. B., Lien, E. J., Koda, R. T. (1986) Oculotoxicities of systemically administered drugs. J. Ocul. Pharmacol. 2: 385-404
11. Kurata, T., Aoki, H., Okazaki, O., Hakusui, H., Esumi, Y., Mitsugi, K., Katami, Y., Watanabe, I., Ohbu, Y., Okada, M. (1991) The pharmacokinetics of DR-3355 (IV): Absorption, distribution and excretion after a single oral administration to monkeys. Xenobio. Metab. Dispos. 6: 143-152
12. Larsson, B. S (1993) Interaction between chemicals and melanin. Pigment Cell Res. 6: 127-133
13. Larsson, B., Tjälve, H. (1979) Studies on the mechanism of drug-binding to melanin. Biochem. Pharmacol. 28: 1181-1187
14. Leblanc, B., Jezequel, S., Davies, T., Hanton, G., Taradach, C. (1998) Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul. Toxicol. Pharmacol. 28: 124-132
15. Lindquist, N. G. (1973) Accumulation of drugs on melanin. Acta Radiologica 325: 1-92
16. Potts, A. M. (1964) The reaction of uveal pigment in vitro with polycyclic compounds. Invest. Ophthalmol. Vis. Sci. 3: 405-416
17. Salazar-Bookaman, M. M., Wainer, I., Patil, P. N. (1994) Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J. Ocul. Pharmacol. 10: 217-239
18. Shimada, K., Baweja, R., Sokoloski, T., Patil, P. N. (1976) Binding characteristics of drugs to synthetic levodopa melanin. J. Pharm. Sci. 65: 1057-1060
19. Siefert, H. M., Kohlsdorfer, C., Steinke, W., Witt, A. (1999) Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: Tissue distribution in male rats. J. Antimicrob. Chemother. 43: (Suppl. B) 61-67
20. Stein, G. E. (1996) Pharmacokinetics and pharmacodynamics of newer fluoroquinolones. Clin. Infect. Dis. 23: (Suppl. 1) S19-S24
21. Stepien, K. B., Wilczok, T. (1982) Studies of the mechanism of chloroquine binding to synthetic dopa-melanin. Biochem. Pharmacol. 31: 3359-3365
22. Tanaka, M., Kurata, T., Fujisawa, C., Ohshima, Y., Aoki, H, Okazaki, O., Hakusui, H. (1993) Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob. Agents Chemother. 37: 2173-2178